FDA Enforcement Class II Terminated

Medtronic EnVeo R Delivery Catheter System (DCS), Models: ENVEOR-L, ENVEOR-L-C, and ENVEOR-US. Designed to replace the native or surgical bioprosthetic aortic heart valve without open heart surgery and without concomitant surgical removal of the failed valve.

Recall: Z-2546-2016 · Reported August 24, 2016

Enforcement

Recall Number
Z-2546-2016
Event ID
74796
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Medtronic Cardiovascular Surgery-the Heart Valve Division
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
August 24, 2016
Initiation Date
August 3, 2016
Classification Date
August 16, 2016
Termination Date
March 31, 2017
Address
1851 E Deere Ave, N/A, Santa Ana, CA, 92705-5720, United States

Description

Medtronic EnVeo R Delivery Catheter System (DCS), Models: ENVEOR-L, ENVEOR-L-C, and ENVEOR-US. Designed to replace the native or surgical bioprosthetic aortic heart valve without open heart surgery and without concomitant surgical removal of the failed valve.

Reason

Potential for vascular trauma with the use of the Medtronic EnVeo R Delivery Catheter System (DCS).

Code Info

all lots

Distribution

Worldwide Distribution -- US, Australia, Austria, Belgium, Brazil, Colombia, Costa Rica, Czech Republic, Denmark, Dominican Republic, Egypt, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Iran, Ireland, Israel, Italy, Kazakhstan, Korea, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Macedonia, Malaysia, Morocco, Netherlands, New Zealand, Norway, Oman, Panama, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Trinidad and Tobago, Tunisia, Turkey, United Arab Emirates, United Kingdom, and Venezuela.

Quantity

7,319 units